ADVIA IMMUNO MODULAR SYSTEM (IMS) B-TYPE NATRIURETIC PEPTIDE (BNP) ASSAY

Test, Natriuretic Peptide

BAYER HEALTHCARE, LLC

The following data is part of a premarket notification filed by Bayer Healthcare, Llc with the FDA for Advia Immuno Modular System (ims) B-type Natriuretic Peptide (bnp) Assay.

Pre-market Notification Details

Device IDK051265
510k NumberK051265
Device Name:ADVIA IMMUNO MODULAR SYSTEM (IMS) B-TYPE NATRIURETIC PEPTIDE (BNP) ASSAY
ClassificationTest, Natriuretic Peptide
Applicant BAYER HEALTHCARE, LLC 511 BENEDICT AVE. Tarrytown,  NY  10591
ContactAndres Holle
CorrespondentAndres Holle
BAYER HEALTHCARE, LLC 511 BENEDICT AVE. Tarrytown,  NY  10591
Product CodeNBC  
CFR Regulation Number862.1117 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2005-05-16
Decision Date2005-06-13
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.